Abstract
Lumbar disc herniation (LDH) is a low back pain disorder and associated with several single nucleotide polymorphisms (SNPs). However, the role of brain-derived neurotrophic factor (BDNF) and BDNFOS gene in LDH susceptibility remains unknown. To examine whether the variants contribute to LDH, 7 SNPs were genotyped in 380 patients and 692 healthy controls among Han Chinese population. Multiple genetic models, stratification by age/gender and haploview analysis was used by calculating odds ratio (OR) and 95% confidence intervals (CIs). Rs11030064 in BDNFOS gene was associated with modified susceptibility for LDH at age ≤50 years but three loci (rs6265, rs11030104 and rs10767664) of BDNF gene increased LDH risk at age >50 years. Further, rs11030096 polymorphism in BDNFOS gene was associated with LDH the increased susceptibility of LDH in females. Haplotype analysis shown that haplotype “GCC” in the block (rs988712, rs7481311, and rs11030064) increased LDH risk (OR = 1.49, 95% CI = 1.06–2.10, p = 0.022) at age ≤50 years. However, there was no significant association between BDNF/BDNFOS gene and LDH risk in the overall before stratified analysis. For the first time, our results provide evidence on polymorphism of BDNF / BDNFOS gene associated with LDH risk in Chinese Han population.
Similar content being viewed by others
Introduction
Lumbar disc herniation (LDH) is one of the more common spinal diseases caused by the degeneration and the displacement of nucleus pulposus or annulus fibrosis beyond the intervertebral disc space1. LDH is characterized with low back and leg pain resulting from the degenerated lumbar disc compressing the spinal nerve root. It is currently believed that some inflammatory mediators contribute to the radicular pain besides mechanical deformation. Recently, studies have proven that Th17 cells and IL-17 was infiltrated and expressed in intervertebral disc tissues and may contribute a lot to the local inflammation and radicular pain2. In addition, the accumulation of lymphocytes in local disc tissues is following exposure to autologous nucleus pulposus or injury to the annulus fibrosus3. Inflammatory cells from the intervertebral disc tissues can secrete many pro-inflammatory mediators and regulatory cytokines, such as TNF-α, IL-1β4, nerve growth factor5, and vascular endothelial growth factor6. Numerous studies of its etiology and pathogenesis indicated that LDH is a complicated and multifactorial spine disease affected by various factors, including gender, age, height, smoking habits, physical activity, occupation, vibration trauma, and so on7,8. Despite the specific factors influence susceptibility of symptomatic LDH is still unknown, genetic factors as an important role in the pathogenesis of LDH is gradually acknowledged9. Recent molecular epidemiological studies have pointed to the potential and significant role of polymorphisms in genes associated with various diseases such as LDH10,11,12.
Brain-derived neurotrophic factor (BDNF) known as ANON2 or BULN2 is a type of neurotrophin which include nerve growth factor, neurotrophin 3, and neurotrophin 413. BDNF is located on 11p14.1, spanning approximately 70 kb and containing 11 exons. BDNF, widely distributed in the central nervous system, is a prominent role in the survival, differentiation, growth and development of neurons14. BDNFOS is also mapped in chromosome 11p14.1 and encoded by the genomic locus encoding BDNF. BDNFOS a primate-specific lncRNA that is natural antisense transcript positioned downstream of BDNF in reverse orientation, so it also is known as BDNF antisense RNA (BDNFAS) gene. Previous studies report that BDNFOS has a potential post-transcriptional regulation of BDNF through the formation of double-stranded duplexes15. Baker-Herman et al. found that the increase in BDNF was necessary and sufficient for spinal respiratory plasticity of spinal injury16. BDNF is known as a crucial neuromodulator involved in nociceptive hypersensitivity in the central nervous system and BDNF levels are modified in some persistent pain states as well as in inflammation17,18. Data accumulated in recent years suggest that BDNF gene has been regarded as a significant contributor to the spinal cord injury and spondyloarthritis19,20. Moreover, previous animal studies showed that BDNF also functions in chondrocyte and osteoblast, participates in cartilage development, ossification, and osteogenesis, and plays an important role in bone growth and development, remodeling and regeneration21,22. Consequently, studies concerning the possible association of BDNFOS and BDNF gene with LDH may be particularly interesting for their potential biological significance.
Overwhelming evidence indicates that BDNFOS and BDNF polymorphisms was associated with various spinal disease, such as spinal cord injury and related skeletal disease, including osteoporosis and osteoblast differentiation23,24. To the best of our knowledge, there are no previous studies have investigated the association of risk of LDH and BDNFOS and BDNF polymorphisms. Therefore, a case-control study was carried out to evaluate the possible association of BDNFOS and BDNF gene polymorphisms at allele, genotype, and haplotype interface with development of LDH among Chinese Han population.
Results
Characteristics of patients and controls
In this case-control study, we collected and analyzed 380 cases of LDH (228 males and 152 females) and 692 healthy controls (390 males and 302 females). The mean ages of the patients and the controls were 50.4 ± 12.3 and 48.2 ± 10.4 years, respectively. There were no statistically significant differences (p = 0.248) on the gender distribution between the case and control groups. However, the result revealed the age distribution was statistically significant differences (p < 0.001), suggesting that age may have an effect on the etiology of LDH.
The basic information of the SNPs regarding gene, SNP ID, chromosomal position, role, minor allele frequency (MAF) of cases and controls, Hardy-Weinberg equilibrium (HWE) test results and call rate, were shown in Table 1. Seven SNPs in the BDNFOS and BDNF gene were successfully genotyped for further analysis, and the call rate of SNPs was above 98.51% in case and controls. The genotype distribution of all SNPs in control subjects was in accordance with HWE (p > 0.05).
The association between BDNFOS and BDNF gene and the risk of LDH
Genotype and allele frequencies of the SNPs among the LDH patients and control subjects were shown in Table 2. However, we had not found that any SNPs were significantly associated with LDH risk in the BDNFOS and BDNF gene at a 5% level (Table 2). Further, multiple inheritance models (dominant, recessive and additive models) were applied for analyzing the association by unconditional logistic regression analysis adjusted for age and gender, and there were also no statistically significant differences in patients and controls (p > 0.05) (As shown in Supplement Table 1).
Stratification analysis by age and gender
There were significant associations between the four SNPs and the risk of LDH in stratified analysis by age adjusted for age and gender, as displayed in Table 3. Rs11030064 in BDNFOS gene was observed to be associated with the reduced the susceptibility of LDH at age ≤50 years in codominant model (TC vs. CC, OR = 0.66, 95% CI = 0.45–0.98, p = 0.034), in dominant model (TC/TT vs. CC, OR = 0.65, 95% CI = 0.45–0.93, p = 0.010) and in log-additive model (OR = 0.74, 95% CI = 0.57–0.96, p = 0.023). Conversely, three loci (rs6265, rs11030104 and rs10767664) of BDNF gene increased LDH risk at age >50 years were discovered based on the results of the dominant model (rs6265, TC/TT vs. CC, OR = 1.50, 95% CI = 1.00–2.27, p = 0.035; rs11030104, GA/GG vs. AA, OR = 1.53, 95% CI = 1.01–2.31, p = 0.029; and rs10767664, AT/TT vs. AA, OR = 1.58, 95% CI = 1.05–2.38, p = 0.020) and the log-additive model(rs10767664, OR = 1.32, 95% CI = 1.01–1.73, p = 0.039).
Furthermore, we conducted another stratified analysis of gender adjusted for age and found only rs11030096 polymorphism in BDNFOS gene was associated with LDH, as shown in Table 4. An increased risk of LDH for CC genotype was found among the female subgroup in the recessive model (TT/TC vs. CC, OR = 1.98, 95% CI = 1.05–3.73, p = 0.036), but not between the male subgroup in any genetic model.
Haplotype analyses
The LD and haplotype analyses of the SNPs in the case and control samples were further studied. Among the subpopulation (age ≤50 years), seven SNPs were found to exist in two LD blocks (Block 1: rs988712, rs7481311and rs11030064; Block 2: rs6265 and rs11030104) in BDNFOS and BDNF gene (Fig. 1). The distributions of different haplotypes of BDNFOS and BDNF gene in both the patients of LDH and controls are presented in Table 5. The results showed that the GCT haplotype was lower in LDH patients than controls (p = 0.017), but the GCC haplotype was slightly higher (p = 0.058). Furthermore, haplotype GCC in Block 1 was found to significantly increase the risk of LDH under unconditional logistic regression analysis adjusted for age and gender (OR = 1.49, 95% CI = 1.06–2.10, p = 0.022) (Table 5). However, no relation was found between the other haplotypes and LDH risk.
Discussion
Lumbar disc herniation, one of the most typical lumbar diseases, is determined by various genetic and environmental interactions. It is widely acknowledged that hereditary factors contribute prominently to the risk of LDH and a large amount of genes and SNPs have been identified to be associated with LDH25. However, the contribution of the in SNPs BDNS/BDNSOF gene to LDH is still unclear. Take into account these, in this case-control study, allele, genotype and haplotype frequencies of seven SNPs in the BDNS/BDNSOF gene between LDH patients and healthy controls were compared and stratification analyses by age or gender were conducted. There was not any association was found between polymorphisms and LDH risk in the overall. Our study found three of the seven SNPs (rs6265, rs11030104 and rs10767664) possibly contributed to the susceptibility of LDH at age >50 years, and rs11030064 and GCC haplotype in the block (rs988712, rs7481311, and rs11030064) were related with the risk of LDH at age ≤50 years. In addition, we also found that rs11030096 polymorphism conferred the increased susceptibility to LDH in the female population. To our knowledge, this is the first study that evaluated and showed an association of BDNS and BDNSOF genetic variants with risk of developing LDH in China Han population.
LDH, a degenerative disease related to narrowing of the spinal canal or intervertebral foramina, can lead to spinal pain syndromes and radicular symptoms caused by the generation of nerve root ischemia26. In addition, various inflammatory related factors play a role in inducing lumbar disc degeneration and nervous radical pain, and further accelerating inflammation and intervertebral disc generation; thus, this vicious circle worsens lumbar disc degeneration and pain27,28. BDNF, a neurotrophic protein, is not only related to neuroprotective but also nociceptive hypersensitivity in the central nervous system. There is compelling evidence that BDNF levels are regulated in some persistent pain states as well as in inflammation29. The function of BDNF in the central nervous system has been studied in detail but a role of neurotrophins as important factors in inflammation has an open research question. BDNF is reported to be involved in inflammatory reactions, and its production is increased in response to pro-inflammatory cytokines30. Some studies are manifested that high BDNF mRNA expression levels have been detected in the synovial fluid cells of osteoarthritis, rheumatoid arthritis, and spondyloarthritis patients31. Spondyloarthritis is the most common pathological change in the spine. Depending on the clinical symptoms there are two basic pathological syndromes: spondylosis related mainly to the intervertebral disc and bone structures of vertebras and myelopathy including spinal cord injury caused by compression32,33. Therefore, we propose a reasonable hypothesis that the pathogenesis of LDH is associated with BDNF.
BDNF is a crucial factorin the cell cycle, neurite outgrowth, and synaptic plasticity and has been linked to many human brain disorders34. Sequence variations in the BDNF gene may lead to variations in gene expression, further to affect the function of the protein. Several single-nucleotide polymorphisms (SNPs) in the BDNF gene have been identified, including rs6265, rs11030104 and rs10767664 polymorphisms which are located in the coding exon, promoter and intron region, respectively. Rs6265 (Val66Met), a common substitution of G to A, was identified in the 5′pro-BDNF sequence which leads to a change of Valine (Val) to Methionine (Met) at codon 66. This substitution seemed to be of functional significance to affect intracellular trafficking, packaging of proBDNF, and activity dependent secretion of BDNF35. In the present case-control study, our result shows that rs6265 and two intronic SNPs, rs11030104 and rs10767664 in BDNF gene exhibited an increased risk of LDH in the dominant model at age >50 years, suggesting that these BDNF variants are likely to be susceptibility markers for LDH. We speculate it seems like a plausible explanation that age-related degenerative changes occurring within the lumbar intervertebral disc also be affected by the transcription efficiency and function of the BDNF gene. However, the mechanisms still need more functional studies to testify. Moreover, we could not exclude the possibility that the deficiency of association in a certain group might be a consequence of the limited sample size.
BDNFOS, positioned downstream of BDNF, play an important role in tissue-specific regulation of BDNF. It has been reported that inhibition of BDNF-AS upregulates BDNF mRNA, which subsequently increases protein levels and stimulates neuronal outgrowth and differentiation36,37. However, studies based on this BDNFOS gene are very few. In our result, rs11030064 in BDNFOS gene was found by the association with decreased LDH risk in codominant, dominant and log-additive models at age ≤50 years. In addition, we also found rs11030096 of BDNFOS gene in the recessive model (CC vs. TT-TC) has increased 1.98-fold risk of LDH in females compared to males. This result demonstrated that rs11030096 of BDNFOS are associated with susceptibility to LDH in Chinese Han population and also the risk association of the polymorphisms is gender dependent. However, these results mean that larger sample sets are needed to affirm and BDNF/BDNFOS gene participated in lumbar disc degeneration is desired to investigate in future studies.
Several limitations of this study should not be ignored. Firstly, the subjects of investigation were enrolled from the identical hospital and therefore selection bias is could not rule out. However, all observed genotype frequencies in controls were in agreement with HWE, which may reduce the bias to some degree. Secondly, the number of cases in our study was not large we cannot preclude false-negative results. So, larger sample size and further confirmation in other ethnic populations are needed for further verification. Thirdly, some potential confounding factors such as occupational exposures, and physical activity were not included in our analysis and should be assessed in the future. Despite the limitations mentioned above, the results of our present study provided scientific evidence about BDNS/BDNSOF gene with LDH in the future studies.
In summary, our present study provided evidence that the variants of BNDF/BDNFOS gene had a significant effect on the risk of LDH in the Chinese Han population especially more than 50 years old, which has not previously been reported. Although a larger sample size, more diverse populations should be conducted to confirm and extend our findings, we believe that the BNDF/BDNFOS gene is a new insight into the LDH and the functional role of BNDF/BDNFOS gene in LDH is necessary to study.
Materials and Methods
Study participants
Using a case-control design, 380 patients with LDH and 692 controls were enrolled. All patients were recruited from the Second Affliated Hospital of Inner Mongolia Medical University and The Hohhot First Hospital. The inclusion criteria for patients were: patients who had typical clinical symptoms and physical signs; and patients with LDH confirmed by image examinations including computed radiography, computed tomography, and/or magnetic resonance imaging (MRI). LDH symptoms were those described as follows: (1) lower back pain, (2) pain in the inferior lumbar part of the spine and regional typical sciatica; (3) difficulty in straight-leg raising test and augmentation test; (4) the limited lumbar flexion range38. Lumbar spine MRI confirmed the patients with LDH according to the Pfrrmann grading system39. Patients with complicated blood diseases, autoimmune diseases, tumors, trauma, rheumatoid arthritis, and related lumbar spine disease containing lumbar spinal stenosis, spinal congenital dysplasia, intraspinal tumor, and spondylolisthesis were excluded from this study. The controls were healthy volunteers from the medical examination during the same period and not scanned by MRI and no history of sciatica and low back pain. Inclusion criteria of the control group were: (1) individuals had no medical and family history of lumbocrural pain; (2) individuals without spinal instability from trauma, scoliosis, spondylolisthesis, osteoarthritis, rheumatism and rheumatoid arthritis; (3) individuals without infections and any history of tumors. All studied individuals were Chinese Han subjects tracing back at least three generations.
Data collection
This study was approved by the ethics committee of the Second Affliated Hospital of Inner Mongolia Medical University and The Hohhot First Hospital, and conformed to the ethical principles for medical research involving humans of the World Medical Association Declaration of Helsinki. All participants signed informed consent forms before participating in this study. Individual demographics information was collected with a standard questionnaire conducted by well-trained interviewers. Subsequently, about 5 mL venous blood sample from each participant was collected into tubes containing ethylenediamine tetraacetic acid (EDTA) for anticoagulation. Genomic DNA was extracted from peripheral blood samples using a Whole Blood Genomic DNA Extraction Kit (Tiangen Biotech, Beijing, China) according to the manufacturer’s instructions. The purity and concentration of the DNA samples were evaluated with the NanoDrop 2000C (Thermo Scientifc, Waltham, Massachusetts, USA). The isolated DNA was stored at −80 °C until analysis.
SNP genotyping
Seven candidate SNPs in the BDNFOS and BDNF gene were selected with the minor allele frequency (MAF) >0.05 in Han Chinese from the 1000 Genome Projects. Sequenom MassARRAY assay (Sequenom, San Diego, CA, USA) was used for detection of BDNFOS and BDNF gene polymorphisms. The primers for amplification and single base extension were designed using the Sequenom MassARRAY Assay Design 3.0 Software (San Diego, California, USA). The data was collected and analyzed by Sequenom Typer 4.0 Software as previously described40. Genotyping was carried out by two laboratory personnel in a double-blinded fashion. In order to confirm the results, about 10% of the samples were randomly selected to repeat genotyping and the reproducibility was 100%.
Data analyses
The Pearson’s χ2 test and independent sample Student’s t-test were applied to assess the differences in the distribution of demographic characteristics between cases and controls. Fisher’s exact tests for HWE were performed by comparing the observed and expected genotype frequencies to calculate the genotype frequencies among the controls. Pearson Chi-squared test or fisher exact test was used to compare the allelic and genotype frequencies of each SNP between patients with LDH and controls. Odds ratios (OR) and 95% confidence intervals (CI) were calculated to estimate the association between BDNFOS/BDNF gene and the risk of LDH using unconditional logistic regression analysis with or without adjustment for potential confounding. The wild-type allele was used as a reference. Multiple genetic model analyses (codominant, dominant, recessive and log-additive) were applied using SNPstats software (http://bioinfo.iconcologia.net/snpstats/start.htm) to assess the association between SNPs and LDH. Further, we calculated stratification factors using age (≤50 and >50 years) and gender (male and female) to adjust for possible cofounders. Finally, the pairwise linkage disequilibrium (LD), haplotype construction and genetic association of polymorphism loci were assessed using the Haploview software package (version 4.2) and the SHEsis software (http://analysis.bio-x.cn/myAnalysis.php). Statistical analyses were performed using SPSS software (version 21.0, IBM Corporation, Armonk, NY, USA). All p values of statistical tests were two-sided, and p ≤ 0.05 was considered as statistically significant.
Data availability
All data generated or analyzed during this study are included in this manuscript.
References
Lei, H. et al. Short-term study on risk-benefit outcomes of two spinal manipulative therapies in the treatment of acute radiculopathy caused by lumbar disc herniation: study protocol for a randomized controlled trial. Trials 16, 122 (2015).
Zhang, W. et al. Th17 cell frequency and IL-17 concentration correlate with pre- and postoperative pain sensation in patients with intervertebral disk degeneration. Orthopedics 37, 685–691 (2014).
Kanerva, A. et al. Inflammatory cells in experimental intervertebral disc injury. Spine 22, 2711–2715 (1997).
Hoyland, J. A., Maitre, C. L. & Freemont, A. J. Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology 47, 809–814 (2008).
Richardson, S. M., Doyle, P., Minogue, B. M., Gnanalingham, K. & Hoyland, J. A. Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis research & therapy 11, R126 (2009).
Haro, H., Kato, T., Komori, H., Osada, M. & Shinomiya, K. Vascular endothelial growth factor (VEGF)-induced angiogenesis in herniated disc resorption. Journal of Orthopaedic Research 20, 409–415 (2002).
Zhang, Y. G. et al. A Controlled Case Study of the Relationship between Environmental Risk Factors and Apoptotic Gene Polymorphism and Lumbar Disc Herniation. American Journal of Pathology 182, 56–63 (2013).
Suzuki, S. et al. Excessive reactive oxygen species are therapeutic targets for intervertebral disc degeneration. Arthritis Research & Therapy 17, 316 (2015).
Battié, M. C., Videman, T., Levälahti, E., Gill, K. & Kaprio, J. Genetic and environmental effects on disc degeneration by phenotype and spinal level: a multivariate twin study. Spine 33, 2801–2808 (2008).
Huang, X. et al. Interleukin 6 (IL-6) and IL-10 Promoter Region Polymorphisms Are Associated with Risk of Lumbar Disc Herniation in a Northern Chinese Han Population. Genet Test Mol Biomarkers 21, 17–23 (2017).
Zhu, L. et al. Association between genetic polymorphism of telomere-associated gene ACYP2 and the risk of HAPE among the Chinese Han population: A Case-control study. Medicine 96, e6504 (2017).
Duan, X. et al. Genetic association of PLCE1, C11orf92–C11orf93, and NOC3L with colorectal cancer risk in the Han population. Tumor Biology 35, 1813–1817 (2014).
Benarroch, E. E. Brain-derived neurotrophic factor: Regulation, effects, and potential clinical relevance. Neurology 84, 1693–1704 (2015).
Hempstead, B. L. Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions. Trans Am Clin Climatol Assoc 126, 9–19 (2014).
Amen, A. M., Pham, D. L. & Meffert, M. K. Post-transcriptional Regulation by Brain-Derived Neurotrophic Factor in the Nervous System, (Springer International Publishing, 2016).
Baker Herman, T. L. et al. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nature Neuroscience 7, 48–55 (2004).
Vanelderen, P. et al. The role of brain-derived neurotrophic factor in different animal models of neuropathic pain. European Journal of Pain 14, 473.e1–9 (2010).
Jing, Y. et al. The role of brain-derived neurotrophic factor in experimental inflammation of mouse gut. European Journal of Pain 14, 574–579 (2010).
Leech, K. A. & Hornby, T. G. High-intensity locomotor exercise increases brain-derived neurotrophic factor in individuals with incomplete spinal cord injury. Journal of Neurotrauma 34, 1240–1248 (2016).
Rihl, M. et al. Involvement of neurotrophins and their receptors in spondyloarthritis synovitis: relation to inflammation and response to treatment. Annals of the Rheumatic Diseases 64, 1542–1549 (2005).
Hutchison, M. R., Bassett, M. H. & White, P. C. SCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation. Molecular Endocrinology 24, 193–203 (2010).
Aiga, A. et al. Expression of neurotrophins and their receptors tropomyosin-related kinases (Trk) under tension-stress during distraction osteogenesis. Acta Medica Okayama 60, 267–277 (2006).
Guimarães, P. E. et al. DNA polymorphisms as tools for spinal cord injury research. Spinal Cord 47, 171–175 (2009).
Yang, M. et al. Genetics association study and functional analysis on osteoporosis susceptibility gene BDNF. Hereditas 39, 726–736 (2017).
Colombini, A. et al. BsmI, ApaI and TaqI Polymorphisms in the Vitamin D Receptor Gene (VDR) and Association with Lumbar Spine Pathologies: An Italian Case-Control Study. Plos One 11, e0155004 (2016).
Cano-Gómez, C., Rúa, J. R. D. L., García-Guerrero, G., Juliá-Bueno, J. & Marante-Fuertes, J. Physiopathology of Lumbar Spine Degeneration and Pain. Revista Española De Cirugía Ortopédica Y Traumatología 52, 37–46 (2008).
Bachmeier, B. E. et al. Analysis of tissue distribution of TNF-alpha, TNF-alpha-receptors, and the activating TNF-alpha-converting enzyme suggests activation of the TNF-alpha system in the aging intervertebral disc. Annals of the New York Academy of Sciences 1096, 44–54 (2007).
Kang, J. D., Georgescu, H. I., Mcintyre-Larkin, L., Stefanovic-Racic, M. & Evans, C. H. Herniated lumbar intervertebral discs spontaneously produce matrix metalloproteinases, nitric oxide, interleukin-6, and prostaglandin E2. Spine 21, 271–277 (1996).
Toma, H. et al. Characterization of the neurotrophic response to acute pancreatitis. Pancreas 25, 31–38 (2002).
Jornot, L., Grouzmann, E., Lacroix, J. S. & Rochat, T. BDNF and DPP-IV in polyps and middle turbinates epithelial cells. Rhinology 45, 129–133 (2007).
Barthel, C. et al. Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis. Arthritis Research & Therapy 11, R82 (2009).
Hermann, K. G. et al. Descriptions of spinal MRI lesions and definition of a positive MRI of the spine in axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI study group. Annals of the Rheumatic Diseases 71, 1278–1288 (2012).
Chatley, A., Kumar, R., Jain, V. K., Behari, S. & Sahu, R. N. Effect of spinal cord signal intensity changes on clinical outcome after surgery for cervical spondylotic myelopathy. J Neurosurg Spine 11, 562–567 (2009).
Corey-Bloom, J. et al. Beneficial effects of glatiramer acetate in Huntington’s disease mouse models: Evidence for BDNF-elevating and immunomodulatory mechanisms. Brain Res 1673, 102–110 (2017).
Ninan, I. et al. The BDNF Val66Met polymorphism impairs NMDA receptor-dependent synaptic plasticity in the hippocampus. Journal of Neuroscience the Official Journal of the Society for Neuroscience 30, 8866–8870 (2010).
Liu, Q. R. et al. Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Res 1067, 1–12 (2006).
Cathomas, F., Vogler, C., Euler-Sigmund, J. C., de Quervain, D. J. & Papassotiropoulos, A. Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory. Int J Neuropsychopharmacol 13, 975–980 (2010).
Amin, R. M., Andrade, N. S. & Neuman, B. J. Lumbar Disc Herniation. Current Reviews in Musculoskeletal Medicine 10, 1–10 (2017).
Pfirrmann, C. W., Metzdorf, A., Zanetti, M., Hodler, J. & Boos, N. Magnetic resonance classification of lumbar intervertebral disc degeneration. Spine 26, 1873–1878 (2001).
Gabriel, S., Ziaugra, L. & Tabbaa, D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet Chapter 2, Unit2 12 (2009).
Acknowledgements
We are grateful to the individuals for their participation in this study. We also thank the clinicians and hospital staff who contributed to the sample and data collection for this study. We would also like to thank all participants for this manuscript.
Author information
Authors and Affiliations
Contributions
The work presented here was carried out in collaboration between all authors. Yong Zhu and Haiyu Jia carried out the molecular genetic studies and drafted the manuscript. Jiabin Li, Shaodong Ren and Zhi Huang designed the methods and experiments, performed the statistical analyse and interpreted the results. Feng Li and Wenhua Xing designed primers and performed the SNP genotyping experiments. Shunan Li and Xuejun Yang conceived of the study, worked on associated data collection and their interpretation, participated in the design and coordination of the study, and funded the study. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhu, Y., Jia, H., Li, J. et al. Associations between Variants in BDNF/BDNFOS Gene and Lumbar Disc Herniation Risk among Han Chinese People. Sci Rep 8, 12782 (2018). https://doi.org/10.1038/s41598-018-31146-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-31146-6
- Springer Nature Limited
This article is cited by
-
CHRNA5/CHRNA3 gene cluster is a risk factor for lumbar disc herniation: a case-control study
Journal of Orthopaedic Surgery and Research (2019)